This popular drug is faced with a major shortage, says the FDA in a new warning
Manufacturers find it difficult to meet demand.
Many among usrely on drugs In order to stay alive. Whether it is an antibiotic to fight against a new infection or a regularly taken prescription, certain drugs are essential to the well-being of millions of Americans. This is why the problems of supply chain affecting a particular common drug are a source of concern. Read more to find out which major drug shortage, the Food and Drug Administration of the United States (FDA) has just published a warning - and what to do if you are affected.
Read this then:4 major drug shortages that could affect you.
The FDA maintains a database to update consumers on drug shortages.
If you have never been able to fill a special prescription or have trouble finding certain over -the -counter medications (OTC) at the pharmacy, you are barely alone. According to the FDA, drug shortages occur for a number of different reasons. But the Covid pandemic created a persistent problem for the supply chain, which the agency says it was monitoring. There is even a frequent update FDA database that lists allcurrent and recently resolved drug shortages reported to the agency.
"A major reasonFor these shortages has been quality manufacturing problems [and], "the FDA declares in its FAQ of drug shortages." However, there have been other reasons such as production delays from the manufacturer and companies have experienced raw materials and supplier components. ""
Now the FDA has just confirmed a shortage involving a popular medication.
The agency alerts the Americans with a new shortage.
Adderall, the popular medication of attention deficit hyperactivity disorder (ADHD), has recently become more difficult for people to get their hands. On October 12, the FDAconfirmed that this drug is currently in shortage. More specifically, the agency said that there is an "shortage of the immediate formulation of mixed amphetamine salts, commonly mentioned by the brand name Adderall or Adderall IR."
In aPress release published On the same day, the FDA advised patients to consider temporary solutions in the meantime. "Until the supply is restored, there are alternative therapies, in particular the prolonged release version of mixed amphetamine salts available for health professionals and their patients for approved indications of mixed amphetamine salts "Said the agency. "Patients must work with their health professionals to determine their best treatment option."
RELATED:For more up-to-date information, register for our daily newsletter.
The shortage of Adderall has been spreading for some time now.
For many Americans,News from this shortage is not exactly a surprise. In a October 4Vice Report, a lot of peopledescribes the problems Try to find Adderall in several pharmacies across the country. The problem has become so disastrous that some people even considered trying potentially dangerous methods for the drug. "I don't trust the black market. I don't trust him with a stick of a thousand yards", "Ian Wobel, a 33 -year -old public service worker from Missouri, saidVice. "I'm just afraid of trying something different, because I'm so used to what I have been given for so long."AE0FCC31AE342FD3A1346EBB1F342FCB
Patients have also described how difficult it is to work in their daily life without taking Adderall. "My life is upset. My ability to deliver both to work and in my personal life as I am used to is compromised,"Type cassidy, a 37 -year -old man from New Jersey who took Adderall for more than a decade, the magazine told.
Companies have trouble producing enough adderall to meet demand.
Teva, a large manufacturer of Adderall, "is currently experiencing intermittent manufacturing delays in progress", according to the FDA. But it seems that Teva wasgo out since at least August, when it isPut certain dosages of Adderall on Orein of command, as reported by Bloomberg. At the time, a manufacturer's spokesperson told the media that the problem was linked to "supply disturbances" which are in a way "associated with packaging capacity constraints".
On October 12, Teva said the main problem is the number of people who now have orders for Adderall, ABC News reported. "The supply that we are currently manufacturing / distributing is about to be coherent - or more than - our supply at that time last year by the end of this year. The demand is not", a declared the company to the media.
Many Adderall suppliers also seem to be consistent in their production. But the need for this prescription medication, which has skyrocketed since the remote charter increased in the middle of the cocovio pandemic, is simply too much to manage. "Other manufacturers continue to produce mixed amphetamine salts, but there is not enough supply to continue to meet the demand of the American market through these producers," warned the FDA.
Best Life offers the most recent information from high -level experts, new research and health agencies, but our content is not supposed to replace professional advice. Regarding the medication you take or any other health issue you have, always consult your health care provider directly.